Analysis of adverse drug events as a way to improve cancer patient care.

Noelia Vicente OliverosTeresa Gramage-CaroElena Corral de la FuenteEva Delgado-SilveiraAna María Álvarez-Díaz

Published in: European journal of hospital pharmacy : science and practice (2022)

This study opens a new way for better management of ADEs and is the first step in the development of a future technology, which will improve the quality of life of patients.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
papillary thyroid
prognostic factors
emergency department
peritoneal dialysis
patient reported outcomes
young adults
squamous cell
drug induced